Discover
CDIO
Cardio Diagnostics Holdings, Inc.
1.67
1 x 1.60
1 x 1.69
bid
ask
+
0.04
2.45%
10 @ 07:46 AM
1.69 +0.02 (1.20%)
| Ytd | -38.38% | |
| 1y | -61.78% |
1.55
day range
1.72
0.97
52 week range
53.10
| Open | 1.68 | Prev Close | 1.63 | Low | 1.55 | High | 1.72 | Mkt Cap | 3.46M |
| Vol | 28.50K | Avg Vol | 54.74K | EPS | -3.38 | P/E | N/A | Forward P/E | -4.12 |
| Beta | 2.23 | Short Ratio | 0.70 | Inst. Own | 4.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.87 | 200-d Avg | 2.65 | 1yr Est | 2.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-13 | 2024-09 | -0.15 | -0.06 | 0.09 | 60.00% |
| 2024-07-01 | 2024-03 | -0.1 | N/A | N/A | N/A |
| 2024-04-01 | 2023-12 | -0.13 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-08-27 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2024-06-06 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2024-04-19 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2023-06-15 | Benchmark | Upgrade | Speculative Buy | Speculative Buy |
| 2023-05-22 | Northland Capital Markets | Upgrade | Outperform | |
| 2023-04-18 | Benchmark | Upgrade | Speculative Buy |
Profile
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-03-27 | BURTON PAUL FREDERICK | Director | 8.80K | Conversion of Exercise of derivative security |
| 2024-09-05 | DOGAN MEESHANTHINI | Chief Technology Officer | 197.31K | Purchase |
| 2024-09-05 | DOGAN TIMUR | Chief Technology Officer | 197.31K | Purchase |
| 2024-03-27 | INTRATER JAMES | Director | 71.60K | Conversion of Exercise of derivative security |
| 2024-03-27 | LAU STANLEY K | Director | 100.33K | Conversion of Exercise of derivative security |
| 2024-03-27 | LEVY ODED | Director | 71.60K | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Blackrock Inc. | 1.07M | 1.10M | 2.64% |
| 2024-09-29 | Vanguard Group Inc | 232.14K | 239.10K | 0.57% |
| 2024-09-29 | Geode Capital Management, LLC | 184.41K | 189.94K | 0.46% |
| 2024-09-29 | Northern Trust Corporation | 48.62K | 50.08K | 0.12% |
| 2024-09-29 | State Street Corporation | 43.50K | 44.80K | 0.11% |
| 2024-09-29 | PNC Financial Services Group, Inc. | 40.50K | 41.71K | 0.10% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 232.14K | 239.10K | 0.57% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 116.77K | 120.27K | 0.29% |
| 2024-10-30 | Fidelity Total Market Index Fund | 27.50K | 28.32K | 0.07% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 21.00K | 21.63K | 0.05% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 11.94K | 12.30K | 0.03% |
Split
| Split | Date |
|---|---|
| 1 : 30 | 2025-05-13 |